Further studies will be required to evaluate whether the impaired nerve conduction might be contributing to the nuclei displacement and whether vemurafenib could be acting to improve LAMA2-CMD neuropathy in the hindlimbs of dyW−/− mice. Here, LAMA2 is linked to neuropathy.